Savencia's Milk Problem: A Cheese Giant Squeezed at Both Ends

Savencia is exactly the kind of business I want to want: people have to eat, and cheese is about as mission-critical as groceries get. St Môret, Caprice des Dieux, RichesMonts, Tartare — these are the French brands that sit in the dairy aisle year after year, passed down through a family-run company more than a century old.

So when this cheese maker reported that its profits had fallen by about a third, I wanted to understand the machinery underneath before reaching for either the bearish or the contrarian reading. The headline number looks like trouble. The story under it is more interesting: a pricing-power business squeezed by its own raw material, trimming a dividend it can easily afford, and quietly pivoting the whole group toward a higher-margin business.

The raw material that writes the margins

The thing to understand about Savencia is that its biggest cost is also its most volatile one: milk. Cheese is milk that has been concentrated, cultured, salted, and aged — so when the price of the raw input moves sharply, it moves the company's economics sharply, whether that is savencia's fault or not.

That is precisely what happened through 2025. The group described a record surge in milk prices, an unavoidable cost for any dairy processor. Full-year revenue held at €6.96 billion, down 2.6% in reported terms but still up about 1.6% organically. The damage showed up below the top line: net income attributable to shareholders fell to €75 million, a drop of roughly 30% from €107 million, and the operating margin thinned to about 2.3% of sales.

Why so thin? Because a dairy company has two ways to absorb a milk shock, and both sting. It can pass the higher cost through to the shelf price, which tests its pricing power; or it can hold prices and eat the margin. Savencia tried the first. In European cheese, the price increases largely went through — and it cost it volume, as shoppers traded down. When the higher milk cost meets consumer pushback at the register, the margin gets squeezed from both directions at once. Add a currency drag from South American currencies and the US dollar, and a business that grows revenue in local currency can watch its reported euro profit fall anyway.

Cheese remains the core of the franchise: Cheese Products account for 57.7% of consolidated revenue.

A dividend cut that is not what it looks like

Here is where the story gets counter-intuitive, and why I think the market's reflexive "bad earnings, cut the dividend" read is the wrong one.

Savencia reduced its dividend for fiscal 2025 from €1.60 to €1.40 a share, the €1.40 submitted to shareholders at the April 2026 meeting. On its face, a 12.5% cut by a company known as a quiet income name is a red flag. But look at the payout, and the cut is not about an ability to pay. Against earnings per share of €5.73, a €1.40 dividend is a payout ratio of roughly a quarter. The company is paying out about one euro in four of what it earns.

A payout that thin does not get cut because the check is in danger. It gets cut because the controlling family wants the cash for something else — a signal about capital allocation, not a distress flare. And the something else is worth understanding.

The pivot toward higher-margin foodservice

Savencia's margin problem is structural, not just cyclical. Processing commodity milk into supermarket cheese is a thin-margin business almost by design; the brands carry pricing power, but the spread between milk cost and retail cheese price is narrow. The answer management has chosen is to move the group up the value chain.

The group is folding its cheese business together with the chocolate activities of its affiliate Savencia Gourmet — home to Valrhona, the reference brand in gastronomy chocolate — to build a bigger "Premium Foodservice" operation, pairing Valrhona with its professional cream brand Elle & Vire. The chocolate business being brought in is meaningful: roughly €800 million of revenue, valued at about €394 million including debt, and funded in part with €175 million of subordinated securities at a 4.57% coupon. It is a family-controlled company borrowing to buy its way into higher-margin, less price-commoditized foodservice — chocolate and premium cream carry a very different margin structure than yellow cheese on a supermarket shelf.

Where 2026 now stands

The question the half-year accounts answer is whether the squeeze is ending. And the evidence suggests the cycle is at a hinge.

The 2025 pain came as milk prices surged. The 2026 backdrop looks different: European milk production has been running significantly higher, up about 5% year over year early in 2026, more supply means cheaper input for Savencia's factories, and the trade has called for a better dairy outlook in the second half of 2026. Cheaper milk is, mechanically, good for a cheese maker's margins — the input-cost squeeze of 2025 should ease.

But the other end of the hinge still has to resolve. Q1 2026 revenue was still slightly negative on a like-for-like basis (down 0.4%), with cheese down 1.4%, Cheese Products saw a 1.4% decline on a comparable basis, even as management pointed to resilience in volumes and mix. More plentiful milk also pressures the industrial dairy and commodity-cheese prices Savencia sells and buys, and the currency headwinds of 2025 have not gone away. So 2026 is shaping up as a year with relief on the input side and continuing pressure on the output side — a margin repair that may arrive slowly, not a clean reopening.

What Savencia is, and is not

Let me be plain about the portfolio role, because this is where a name like Savencia tempts investors into the wrong frame. On the surface it looks like an income stock: ~2.2% dividend yield at around €62 a share, a low double-digit P/E on depressed earnings, a real-economy franchise. That is not a yield shortcut. The dividend has been cut, and looking back across the past decade it has moved around — up some years, down others — rather than compounding the way a true dividend grower compounds. This is a value play on the equity yield curve, not a dividend-growth compounder: the upside is that the milk cycle turns and margins — and with them the dividend — begin to recover from a depressed base.

The risk deserves equal weight. The long-term trend in retail dairy is not in the powerful case's favor: thin structural margins, European volumes that shrink when prices go up, currency swings that pinch people who think in dollars, and a family-controlled structure where minority shareholders accept the founding family's capital-allocation calls. The pivot into premium chocolate and foodservice is a genuine attempt to fix the structural skinny margins, but it is early and financed with new debt.

I wouldn't frame Savencia as a stock to buy on a falling price just because the yield looks okay. I would frame it as a question worth watching: whether the milk cycle turns, and whether the mix shift to higher-margin foodservice can translate a depressed 2.3% operating margin — and a cut-but-affordable dividend — back into something that looks like durable income growth. Until the half-year numbers show that, the case rests on a thesis, and a thin-margin thesis is one you have to ask hard questions of, not one the company owes you.